Description

Methyl 4-(1-(Benzo[D]Thiazol-6-Ylsulfonyl)-5-Chloro-1H-Indol-2-Yl)Butanoate is a high-purity, advanced pharmaceutical intermediate designed for complex synthesis pathways. This compound is critical for research and development in medicinal chemistry, offering a sophisticated molecular scaffold for creating novel therapeutic agents. It is primarily utilized by pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new active pharmaceutical ingredients (APIs), particularly in oncology and other specialized therapeutic areas.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of novel drug candidates, especially for targeted therapies.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes.
• Oncology Drug Development: A crucial precursor for the development of potential anti-cancer agents due to its specific indole and benzothiazole-based structure.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for pharmaceutical clients.
• Academic Research: Utilized in university and institutional labs for exploratory research in heterocyclic and sulfonamide chemistry.
• High-Value Fine Chemical Production: Integrated into multi-step synthesis sequences for the production of complex, high-margin specialty chemicals.

Basic Information

Product Name	Methyl 4-(1-(Benzo[D]Thiazol-6-Ylsulfonyl)-5-Chloro-1H-Indol-2-Yl)Butanoate
CAS No.	927961-17-9
Molecular Formula	C20H17ClN2O4S2
Molecular Weight	448.94 g/mol
Synonyms	Methyl 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl]butanoate; 4-[1-(Benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl]butanoic acid methyl ester; 927961-17-9; Butanoic acid, 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl]-, methyl ester; Methyl 4-(1-(benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl)butyrate
EINECS	Contact for details

Quality Control

Our production of Methyl 4-(1-(Benzo[D]Thiazol-6-Ylsulfonyl)-5-Chloro-1H-Indol-2-Yl)Butanoate adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing all specifications are provided with every shipment to guarantee traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The compound may be sensitive to moisture and should be handled under inert conditions for long-term storage. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.